PNC-27: A Strictly In Vitro Compound, and Why That Restriction Is the Interesting Part
PNC-27 incorporates an HDM-2-binding domain and is studied in cell-culture cancer models. It is the one compound in this catalogue where the in vitro restriction is not boilerplate — it is the actual research context. Here is the mechanism and the honest state of the evidence.
- PNC-27 is a synthetic peptide incorporating a p53-derived HDM-2-binding domain fused to a membrane-penetrating sequence.
- HDM-2 (the human homologue of MDM2) is a negative regulator of the p53 tumour suppressor and is overexpressed in many cancer cell lines, which is why it is a long-standing oncology research target.
- Published work is in cell culture — the compound is studied for membrane disruption in cancer cell lines relative to non-transformed cells.
- This is an in vitro research compound in the literal sense: the evidence base is cell-culture work, and no clinical efficacy in humans has been established.
- Popular Peptides supplies PNC-27 at greater than 99% purity with a batch-specific third-party certificate of analysis.
- For in vitro laboratory research use only — not for human or veterinary consumption, and not a treatment for any disease.
The one where "in vitro only" is the actual research context
Every compound on this site carries an in vitro research-use-only designation. For most of them it is a regulatory statement about how the material is supplied.
For PNC-27 it is also a plain description of where the science currently is. The published work is cell-culture work. That is not a hedge — it is the state of the evidence, and anyone selling it as more than that is misrepresenting it.
The mechanism
PNC-27 is a synthetic peptide with two functional parts:
1. A segment derived from **p53** that binds **HDM-2**.
2. A **membrane-penetrating sequence** that allows the construct to reach its target.
HDM-2 — the human homologue of MDM2 — is a negative regulator of p53, the tumour suppressor sometimes called the guardian of the genome. HDM-2 binds p53 and marks it for degradation. Many cancer cell lines overexpress HDM-2, which is one route by which p53 function is suppressed without p53 itself being mutated.
That makes the HDM-2/p53 interaction a long-standing and legitimate oncology research target, pursued by many groups with many different molecules. PNC-27 is one approach among them.
Published work has studied the peptide's effect on cancer cell lines in culture, with reported membrane disruption in transformed cells relative to non-transformed ones.
Related compounds in the catalogue occupying adjacent research space include thymosin alpha-1 in immune modulation and epitalon in cellular ageing research. Molecular data is in our reference library.
Being straight about the evidence
PNC-27 attracts more overstatement than anything else in this catalogue, so here is the plain version.
The research is **cell-culture research**. Effects observed in cancer cell lines in a dish are the beginning of an investigation, not the end of one. The history of oncology is substantially a history of compounds that performed impressively in vitro and did not translate.
**No clinical efficacy in humans has been established.** PNC-27 is not a treatment for cancer or for anything else. It is not approved by Health Canada, the FDA or any other regulator, and it is supplied here strictly as a laboratory reagent for in vitro work.
If you are researching HDM-2/p53 interaction, membrane-penetrating peptide constructs, or comparative cell-line work, it is a legitimate and interesting tool. That is the use case, and it is the only one.
What to verify before ordering
For a compound used in cell-culture work, identity and purity are not paperwork — contaminants and incorrect sequences will quietly corrupt your results before you notice anything is wrong.
- —**HPLC for purity, LC-MS for identity**, performed by an independent third-party laboratory, not by us.
- —**Published-batch purity averaging above 99%**, measured across the batches we publish.
- —**Enter your lot number** and read the certificate of analysis for the exact vial you received, or review all published results first.
And the supply chain: **shipped from Vancouver, BC**, typically 2 to 5 business days, tracked, insured, discreetly packaged, priced in Canadian dollars, free shipping over $300 CAD. No customs clearance, no border seizure, no unexplained multi-week delay. Most research compounds bought in Canada arrive from overseas and accept that risk on every order. Ours do not cross a border.
Frequently asked questions
What is PNC-27?
PNC-27 is a synthetic peptide incorporating a p53-derived HDM-2-binding domain fused to a membrane-penetrating sequence. It is supplied for in vitro laboratory research use only.
What is HDM-2?
HDM-2 is the human homologue of MDM2, a negative regulator of the p53 tumour suppressor. It binds p53 and marks it for degradation, and it is overexpressed in many cancer cell lines — which is why the HDM-2/p53 interaction is a long-standing oncology research target.
Is PNC-27 a cancer treatment?
No. The published work is cell-culture research, no clinical efficacy in humans has been established, and PNC-27 is not approved by any regulator. It is supplied strictly as a laboratory reagent for in vitro work and is not a treatment for any disease.
What research uses PNC-27?
Studies of HDM-2 and p53 interaction, membrane-penetrating peptide constructs, and comparative work between transformed and non-transformed cell lines in culture.
Where can I buy PNC-27 in Canada?
Popular Peptides supplies PNC-27 for in vitro laboratory research use, shipped domestically from Vancouver, BC with a third-party certificate of analysis verifiable by lot number. It is not sold for human or veterinary consumption.
PNC-27 is supplied for in vitro laboratory research use only. It is not approved by Health Canada for therapeutic use, is not a treatment for any disease, and is not intended for human or veterinary consumption. 18+.
Every batch we sell is independently third-party tested, with the full Certificate of Analysis published and checkable by lot number.